Cambrex (CBM) Showing Signs Of A Dead Cat Bounce Today

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified Cambrex ( CBM) as a "dead cat bounce" (down big yesterday but up big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Cambrex as such a stock due to the following factors:

  • CBM has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $24.6 million.
  • CBM has traded 84,382 shares today.
  • CBM is up 3.2% today.
  • CBM was down 6.4% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in CBM with the Ticky from Trade-Ideas. See the FREE profile for CBM NOW at Trade-Ideas

More details on CBM:

Cambrex Corporation, a life sciences company, provides various products and services for the development and commercialization of new and generic therapeutics worldwide. CBM has a PE ratio of 18.5. Currently there is 1 analyst that rates Cambrex a buy, no analysts rate it a sell, and 1 rates it a hold.

The average volume for Cambrex has been 506,800 shares per day over the past 30 days. Cambrex has a market cap of $1.2 billion and is part of the health care sector and drugs industry. The stock has a beta of 1.75 and a short float of 1.4% with 1.10 days to cover. Shares are up 76.4% year-to-date as of the close of trading on Tuesday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

Hopes for Tax Reform, Less Regulation Lift Indices

Today's Weak On High Volume Stock: Cambrex (CBM)

Cambrex (CBM) Is Today's Strong On High Volume Stock

Cambrex (CBM) Weak On High Volume Today

Today Cambrex (CBM) Hits New Lifetime High